22.418 articles found

Status of fetal tissue transplantation for the treatment of advanced Parkinson disease.

Greene PE, Fahn S.

Neurosurg Focus · 2002-11-15

DOI: 10.3171/foc.2002.13.5.4PMID: 15769072

Treatment of movement disorders with metabotropic glutamate receptors antagonist

BROTCHIE JONATHAN, HILL MICHAEL, CROSSMAN ALAN.

· 2002-11-14

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases

HAYS SHERYL JEANNE, HU LAIN-YEN, LEI HUANGSHU, SCHOLTEN JEFFREY DAVID, WUSTROW DAVID JUERGEN.

· 2002-11-13

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALZHEIMER DISEASE COMPRISING AS MAIN INGREDIENT UNCARIAE RAMULUS ET UNCUS

KANG HYUNG WON, KIM SANG HO, LEE GEON MOK, LYU YOUNG SOO.

· 2002-11-13

Therapeutic agent composition and method of use

TRAN LOI H.

· 2002-11-12

Benzoxazines for use in the treatment of parkinson's disease

AUGELLI-SZAFRAN CORINNE ELIZABETH, BOEHME THOMAS, SCHWARZ ROY DOUVILLE.

· 2002-11-08

Benzoxazines for use in the treatment of parkinson's disease

AUGELLI-SZAFRAN CORINNE ELIZABETH, BOEHME THOMAS, SCHWARZ ROY DOUVILLE.

· 2002-11-08

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.

Moro E, Esselink RJ, Benabid AL, Pollak P.

Brain · 2002-11-01

DOI: 10.1093/brain/awf249PMID: 12390968

Fibrotic valvular heart disease subsequent to bromocriptine treatment.

Serratrice J, Disdier P, Habib G, Viallet F, Weiller PJ.

Cardiol Rev · 2002-11-01

DOI: 10.1097/00045415-200211000-00005PMID: 12390688

Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease.

Navan P, Bain PG.

J Neurol Neurosurg Psychiatry · 2002-11-01

DOI: 10.1136/jnnp.73.5.602PMID: 12397168

Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.

Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M.

Folia Phoniatr Logop · 2002-11-01

DOI: 10.1159/000066148PMID: 12417800

The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.

Grantham C, Geerts H.

J Neurol Sci · 2002-11-01

DOI: 10.1016/s0022-510x(02)00274-5PMID: 12417371